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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess and compare the diagnostic accuracy of different PTSD self-report instruments.
B A C K G R O U N D
Target condition being diagnosed
After a traumatic event, some survivors will develop a psychiatric
disorder such as post-traumatic stress disorder (PTSD). PTSD is
characterised by symptoms of re-experiencing of the traumatic
event, avoidance of thoughts and behaviours related to the trau-
matic event, emotional numbing and hyperarousal. In the Diag-
nostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV), acute PTSD is diagnosed if symptoms are present for
at least one month, and chronic PTSD is diagnosed if symptoms
persist for three months or longer. In addition, the disturbance
should cause clinically significant distress or functional impair-
ment (American Psychiatric Association 1994). PTSD is associ-
atedwith substantial health care and economic costs (Walker 2003;
Chan 2009).
The risk of development of PTSD after trauma ranges from about
6% in accident victims to 21% in assault victims (Kessler 1995).
Although incidence rates vary between populations and samples
studied, longitudinal studies (e.g. O’Donnell 2003) and epidemi-
ological surveys (e.g. Breslau 2009) generally show patterns of de-
creased prevalence during the first year after trauma. However,
some trauma survivors do not show a decrease during the first year,
and a minority experience delayed onset of PTSD, meaning that
at least six months has passed between the trauma and the onset
of symptoms (American Psychiatric Association 1994, p. 465).
The presence of PTSD is usually established with a comprehensive
diagnostic interview such as the Clinician-Administered PTSD
Scale (CAPS; Blake 1995), the Structured Clinical Interview for
1Self-report screening instruments for post-traumatic stress disorder (PTSD) in survivors of traumatic experiences (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
DSM-IV Axis I Diagnosis-Patient Edition; First 1996), the Struc-
tured Interview for PTSD (SI-PTSD; Davidson 1997) and the
M.I.N.I. Neuropsychiatric Interview (Sheehan 1998), or with a
full assessment of PTSD symptoms by a clinician. Interviews con-
sist of semi-structured questions based on symptoms in DSM-IV
or the tenth revision of the International Classification of Diseases
(ICD-10); these assessment tools havemultiple response categories
and are administered face-to-face bymental health care profession-
als such as psychologists, psychiatrists or trained nurses. Although
the administration time of these interviews varies (e.g. about 15
minutes for the PTSD module of the SCID I/P and up to 25
to 45 minutes for the CAPS), in general they are relatively time-
consuming.
Efforts to prevent PTSD using brief single-session or multiple-ses-
sion interventions for all victims involved in the traumatic event
have been unsuccessful (see Rose 2009 and Roberts 2009 for re-
views). A more beneficial prevention strategy may be to select
trauma survivors with a probable clinical diagnosis of acute PTSD
using a self-report instrument for further diagnostic procedures,
after which they may receive treatment. A recent Cochrane re-
view showed that trauma-focused cognitive behavioural therapy
(TFCBT) is effective in the treatment of acute PTSD (Roberts
2010).
Randomised clinical trial evidence suggests that chronic PTSD
can be effectively treated with psychological treatments such
as TFCBT or eye movement desensitization and reprocessing
(EMDR; see Bisson 2007; Bisson 2007a, Powers 2010 for reviews).
Pharmacological treatments such as selective serotonin reuptake
inhibitors (SSRIs) may also be effective (Stein 2009), but some
clinical guidelines and consensus statements (e.g. National 2005,
Institute of Medicine 2008) recommend them as a second line of
treatment after TFCBT.
Index test(s)
To facilitate more rapid identification of trauma survivors with a
probable diagnosis of PTSD than is possible with semi-structured
interviews, self-report instruments have been developed. Examples
of such instruments are the Impact of Event Scale (IES; Horowitz
1979), the PTSD Checklist Civilian Version (PCL-C; Weathers
1993), the Posttraumatic Stress Symptom Scale Self-Report Ver-
sion (PSS-SR; Foa 1993), the Davidson Trauma Scale (Davidson
1997a) and the Trauma Screening Questionnaire (TSQ; Brewin
2002). Although most of these instruments consist of items based
on the 17 PTSD symptoms outlined in DSM-IV, shorter and
longer questionnaires have been developed.Most instruments pro-
vide sum scores for each symptom cluster (re-experiencing, avoid-
ance and hyperarousal) and a total PTSD sum score. Usually, the
scores of these self-report instruments are interpreted without ad-
ditional information, such as details of functional impairment or
personal suffering or background characteristics.
In practice, PTSD self-report instruments are administered in spe-
cialised care as well as in public health settings. For example, they
are administered by psychologists and psychiatrists in treatment
settings but also by other professionals or non-professionals in-
volved in the care of individuals exposed to a traumatic event,
such as nurses, social workers or management staff in professions
at high risk of experiencing traumatic events. In addition, they
can be completed at home and returned by mail or administered
through the Internet (e.g. Read 2009). In addition to the fact that
they save time, an advantage offered by these instruments is that
their administration does not require the involvement of trained
clinicians. However, self-report instruments may also offer disad-
vantages in comparison with interviews. Items may not always be
understood, or they may be understood differently by different
patient groups. For instance, the PTSDDSM-IVC3 criterion “in-
ability to recall an important aspect of the trauma” may be en-
dorsed by many accidental injury victims as the result of uncon-
sciousness during the event. A recent study in soldiers deployed to
Afghanistan found that scores obtained with the PSS-SR overesti-
mated true PTSD rates by a factor of about 3.5 (Engelhard 2007a),
possibly because symptoms may have been endorsed that stem not
from a traumatic event (according to the DSM-IV definition) but
rather from another type of stressful experience (e.g. a divorce, a
discharge), or symptomsmay have been endorsed that were already
present before the traumatic event, such as hyperarousal symp-
toms. In addition, several PTSD symptoms overlap with symp-
toms of other anxiety disorders or affective disorders, and this may
result in inflated scores on self-report measures (Engelhard 2007).
Finally, translation versions may not perform as well as original
language instruments because of cultural differences or translation
problems.
Clinical pathway
In general, PTSD self-report instruments may be used for two
purposes. First, they may be useful as a triage test. Rather than
undertaking a clinical interview with all individuals, the self-re-
port instrument is administered first as a selection tool. Only those
individuals who achieve a score above a threshold go on to the
interview to obtain a diagnosis. If the self-report instrument is
sufficiently accurate (sensitive), such a strategy saves resources and
costs (Bossuyt 2006). For example, triagemay be carried out in the
aftermath of mass trauma. In fact, after the 2005 London bomb-
ings, survivors were sent a two-page brief questionnaire, which
included the TSQ (Brewin 2010). Individuals who screened posi-
tive were invited for a more detailed assessment that included the
SCID I/P. Other target groups for triage with PTSD self-report
instruments may include injured trauma patients in general hos-
pitals (e.g. O’Donnell 2008), victims applying for assistance at
victim support agencies (e.g. Dekkers 2009), victims reporting a
crime to the police (e.g. Wohlfarth 2003), soldiers returning from
deployment in war zones (e.g. Bliese 2008), primary care patients
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(e.g. Ouimette 2008) andmembers of the general population (e.g.
Terhakopian 2008).
Second, self-report instruments may replace the structured inter-
view. Although, by definition, an index test (the self-report in-
strument) cannot perform better than the reference standard (the
structured interview), replacement of the time-consuming inter-
view with a much simpler self-report instrument with satisfactory
accuracy may be worthwhile. For example, this approach may be
useful for monitoring treatment outcomes in mental health care
settings, or for research purposes.
Rationale
As has been discussed, a considerable risk for development of
PTSD has been noted in trauma-exposed individuals. Several
strategies have been proposed for prevention or early treatment of
PTSD. It is important to note that brief early psychological inter-
ventions for all, such as debriefing, have proved ineffective and in
some cases even harmful (Rose 2009), whereas early treatment of
PTSD patients using TFCBT has been shown to be an efficacious
alternative (see Roberts 2009). Accurate self-report instruments
would facilitate the identification of individuals with PTSD before
they are referred for treatment.
In recent years, the number of studies evaluating the sensitivity and
specificity of early screening questionnaires in identifying trauma
survivors with early symptoms of PTSD has grown rapidly. ’Sen-
sitivity’ refers to the percentage of individuals with a diagnosis of
PTSD who were correctly identified as such with use of the self-
report instrument, whereas ’specificity’ refers to the percentage of
individuals without PTSD who were correctly identified as such
with use of the instrument. The purpose for which the test is used
determines whether sensitivity or specificity is considered more
important. For instance, when a PTSD self-report instrument is
to be used as a triage test, it should be very sensitive so that as
many true cases as possible can be detected and referred for a more
in-depth clinical interview. On the other hand, if a PTSD self-
report instrument is used to replace a diagnostic interview, a more
balanced trade-off between sensitivity and specificity is required.
The diagnostic accuracy of PTSD self-report instruments has been
described in reviews by Brewin 2005 and Connor 2006. Brewin
2005 reviewed13 separate instruments and found that the sensitiv-
ities of these instruments ranged between .60 and 1.00 and speci-
ficities between .60 and .99. However, until now, no meta-analy-
sis on the diagnostic accuracy of self-report instruments has been
carried out. Therefore, it is not clear whether some instruments
are more accurate than others, or whether accuracy of screening
instruments varies between groups of trauma-exposed individuals.
It is possible that the accuracy of PTSD self-report instruments
depends on the type of trauma to which individuals were exposed.
Some instruments may better tap into post-traumatic stress reac-
tions after accidental injury, whereas othersmay be phrased to bet-
ter reflect combat stress reactions. In addition, the accuracy of self-
report instruments may depend on the time between assessment
and the traumatic incident. In the first months after trauma, it
may be more difficult to distinguish PTSD symptoms from tran-
sient stress reactions.
We will carry out a systematic review of studies evaluating the di-
agnostic accuracy of PTSD self-report instruments (the index test)
in relation to the reference standard, which is a clinical DSM or
ICD diagnosis of PTSDmade with a structured interview. We will
include studies of victims of all types of traumatic events, includ-
ing assault, road traffic accidents and disasters. We will focus on
the accuracy of self-report instruments in diagnosing PTSD rather
than predicting PTSD. DSM-IV states that symptoms should be
present for at least one month before PTSD may be diagnosed;
therefore we will include studies in which the self-report instru-
ment(s) and the interview were administered at least one month
after the trauma and simultaneously (i.e., within a maximum pe-
riod of seven days).
O B J E C T I V E S
To assess and compare the diagnostic accuracy of different PTSD
self-report instruments.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include cross-sectional studies of victims of traumatic events
that compared aPTSDdiagnosis obtainedwith one ormore PTSD
self-report instruments with a PTSD diagnosis obtained with a
structured or semi-structured clinical interview for PTSD used as
the reference (golden) standard. We include studies evaluating one
test in one sample and studies comparing the diagnostic accuracy
of two or more instruments within the same study sample.
Randomised comparisons of test accuracy will be included if data
on sensitivity and specificity of the instruments are provided.
The study population should have been selected randomly or con-
secutively. Studies that have included patients and healthy controls
separately will not be considered.
Studies are included if the PTSD self-report instrument and the
semi-structured interviewwere administeredwithin the sameweek
(seven days). The reason for this is that a longer delay may lead to
misclassification as the result of spontaneous recovery, benefit from
treatment, progression to a more advanced stage of the disease or
occurrence of new symptoms.
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We include studies only when at least four studies have reported
on the accuracy of the same index test in question. These four
studies should have been evaluated by at least two (independent)
research groups. The criterion of at least four studies is arbitrary.
The reason for inclusion of this criterion is that we were concerned
that we would include many studies evaluating self-report instru-
ments that have never been re-tested in independent samples. This
would reduce generalisablity of the study results.
Finally, we will include studies that examined the accuracy of self-
report instruments in diagnosing PTSD, but not studies aimed at
distinguishing ’true’ PTSD from PTSD feigning or malingering.
Previous studies have evaluated whether individuals who were in-
structed on DSM-IV PTSD symptoms could feign a PTSD diag-
nosis (e.g. Calhoun 2000). This issue may be relevant for com-
pensation cases in the legal context but is beyond the scope of our
review.
Participants
We will consider all adult (age ≥ 18 years) study participants,
regardless of gender or ethnicity, who experienced a traumatic
incident according to the DSM-IV PTSD A1 criterion (i.e. “the
person experienced, witnessed or was confronted with an event or
events that involved actual or threatened death or serious injury,
or a threat to the physical integrity of self or others”, American
Psychiatric Association 1994) at least one month before the index
test was administered.
Wewill include participants studied in all settings (e.g. community
(public health services), victim support agencies, primary care, the
army, outpatient clinics, hospital settings).
Index tests
The evaluated index test should be a PTSD self-report instrument
based onDSM or ICD symptoms of PTSD, or aimed at diagnosing
PTSD. General anxiety or psychopathology measures that do not
include a PTSD scale will not be considered.
The following index tests will be considered:
• PTSD Checklist (PCL or PCL-C)
• Civilian Mississippi Scale (CMS)
• Davidson Trauma Scale (DTS)
• Impact of Events Scale (IES)
• Impact of Events Scale
Revised (IES-R)
• Aberdeen Trauma Screening Index
• My Mood Monitor (M-3)
• Penn Inventory for Posttraumatic Stress Disorder (Penn)
• Perdue Posttaumatic Stress Disorder Scale
• PK scale of the MMPI-2 (PK)
• Posttraumatic Diagnostic Scale (PDS)
• Posttraumatic Stress Symptom Scale
Self-Report Version (PSS-SR)
• Posttraumatic Stress Disorder Questionnaire (PTSD-Q)
• Symptom Checklist-90-Revised Crime-Related PTSD Scale
(SCL-90-R)
• Short Form of the PTSD Checklist
• Short Screening Scale for PTSD
• SPAN
• Short Post-Traumatic Stress Disorder (PTSD) Rating
Interview (SPRINT)
• Trauma Screening Questionnaire (TSQ)
• Distressing Event Questionnaire (DEQ)
• Los Angeles Symptom Checklist (LASC)
• Mississippi Scale for Combat-Related PTSD
• Modified PTSD Symptom Scale (MPSS-SR)
• Trauma Symptom Inventory (TSI)
• Self-Rating Scale for PTSD (SRS-PTSD)
• Millon Clinical Multiaxial Inventory
• Harvard Trauma Questionnaire (HTQ)
• Self-Rating Inventory for Posttraumatic Stress Disorder
(SRIP)
• Zelfinventarisatielijst Posttraumatische Stressstoornis (ZIL)
• Screen for Posttraumatic Stress Symptoms (SPTSS)
• Brief DSMPTSD-III-R and DSMPTSD-IV (BPTSD-6)
• Disaster-Related Psychological Screening Test (DRPST)
• Posttraumatic Adjustment Scale
• Los Angeles Symptom Checklist (LASC)
• Mississippi Scale for Combat-Related PTSD
• Acute Stress Disorder Scale
• Modified PTSD Symptom Scale (MPSS-SR)
If the literature search yields a PTSD self-report instrument not
listed here, we will consider it for inclusion.
Target conditions
PTSD as defined by DSM (American Psychiatric Association
1994) or ICD (World Health Organization 2007) criteria.
Reference standards
The reference (’golden’) standards that are considered appro-
priate for establishing a diagnosis of PTSD are semi-structured
clinical interviews for DSM-IV or ICD-10 diagnoses of PTSD.
These interviews include the Structured Clinical Interview for
DSM-IV Axis I Diagnosis-Patient Edition; First 1996), the Com-
posite International Diagnostic Interview (CIDI; World Health
Organization 1997), the M.I.N.I. Neuropsychiatric Interview
(Sheehan 1998), the Diagnostic Interview Schedule (DIS; Robins
2000), the Clinician-Administered Posttraumatic Stress Disorder
Scale (CAPS; Blake 1995), the Structured Interview for PTSD (SI-
PTSD;Davidson 1997) and the PTSDSymptomScale Interview
Version (PSS-I; Foa 1993).
Both the original versions and the translations of these reference
standards will be considered.
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These reference standards will be regarded as appropriate only
if the diagnosis is made by a clinician (psychologist, psychiatrist
or other trained professional such as a nurse) or under the close
supervision of a clinician.
Search methods for identification of studies
The search will incorporate the following methods to identify
completed or ongoing studies.
Electronic searches
Relevant studies will be obtained by searching the following
sources:
• MEDLINE (1950 to date)
• PsycINFO (1970 to date)
• EMBASE (1980 to date)
• PILOTS (Published International Literature on Traumatic
Stress, US Department of Veterans Affairs) (1871 to date)
• OpenGrey
• OAISTER
• MEDION
MEDLINE and PsycINFO search strategies (Appendix 1) will
be translated into appropriate strategies for EMBASE, PILOTS,
OpenGrey, OAISTER and MEDION using relevant controlled
vocabulary and free-text terms, where appropriate. The strategies
listed in this protocol have been cross-validated against known
reports of relevant diagnostic test accuracy (DTA) studies.
Searching other resources
We will also search the following:
• Reference lists of relevant studies;
• Annual conference abstracts of the International Society of
Traumatic Stress Studies;
• Contact investigators, relevant authors seeking information
about unpublished or incomplete studies; and
• Non-English language literature for all searches (when
considered likely to meet inclusion criteria, studies will be
translated).
Data collection and analysis
Selection of studies
Two review authors (MS, NPR) will screen the titles and abstracts
retrieved by the searches. Studies identified as potentially relevant
will be obtained as full text articles, which will be assessed for
inclusion using a checklist based on pre-defined inclusion criteria.
Screening studies for inclusion will be conducted by two review
authors independently (MS, NPR), with disagreements resolved
by consultation with a third review author (JBR).
Data extraction and management
Two review authors (MS, NPR) will independently extract all
relevant data from included studies using a data extraction form.
Disagreements between review authors in data extracted will be
resolved by consultation with a third review author (JIB). Data
extractedwill include numerical data to fill in the 2 × 2 table of true
positives, false positives, false negatives and true negatives, as well
as cut-off scores, details for assessment of quality, study setting,
country, eligibility criteria of study, sample size, age distribution
and gender ratio, prevalence of PTSD and time period between
traumatic incident and assessment. If incomplete data are reported,
we will contact the authors to request additional data.
Assessment of methodological quality
All included studies will be assessed for the likelihood of bias by
two review authors independently, using the QUADAS-2 (quality
assessment tool for systematic reviews of diagnostic test accuracy
studies; Whiting 2011). Disagreements will be resolved by dis-
cussion with a third review author. QUADAS-2 is a generic set
of criteria (see Appendix 2) consisting of four key domains: pa-
tient selection, index test, reference standard and flow of patients
through the study and timing of the index test and reference stan-
dard. Signalling questions are included to allow judgement of the
risk of bias across the four domains (Whiting 2011).
We adapted the original QUADAS-2 instrument by adding sig-
nalling questions relevant to this review to account for biases spe-
cific to the use of semi-structured clinical interviews. For the do-
main “index test”, the following signalling question was added:
“Was internal consistency within an acceptable range (i.e. was
Cronbach’s alpha higher than .70)? (Bernstein&Nunnally 1994)”.
For the domain “reference standard”, extra signalling questions in-
cluded the following: “Was theDSM-IV criterion F (clinically sig-
nificant distress or functional impairment) included in the PTSD
diagnosis?” and “Were data on interviewer variation (i.e. inter-
rater reliability or agreement) for the semi-structured interview
within an acceptable range (i.e. Cohen’s kappa or Intraclass cor-
relation coefficient higher than .60; Landis 1977)?” With respect
to the fourth domain (“flow and timing”), we decided that the
time interval between administration of the index test and the
reference standard should be less than eight days. This (arbitrary)
time interval was chosen to avoid (natural) fluctuations in PTSD
symptoms that are likely to affect the accuracy of the index test(s)
and thus may lead to risk of bias.
Statistical analysis and data synthesis
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We will plot the estimates of sensitivity and specificity of all in-
struments studied in forest plots and in receiver-operating char-
acteristic (ROC) space. These plots will allow visualisation of the
variation in accuracy between studies.
We will meta-analyse pairs of sensitivity and specificity using the
bi-variate random-effects approach (Reitsma 2005) in those stud-
ies with a comparable cut-off value. Summary estimates of sensi-
tivity and specificity together with associated confidence and pre-
diction intervals will be calculated for each type of instrument.
This approach incorporates the following issues relevant for diag-
nostic reviews: (1) imprecision by which sensitivity or specificity
has been measured within each study, (2) variation beyond chance
in sensitivity and specificity between studies, and (3) correlation
that might exist between sensitivity and specificity.
Summary measures of accuracy at a common threshold will be
calculated to determine the consequences in absolute numbers
(numbers of true positives, false positives, etc.) when the test is
used in practice. If studies vary in the threshold they have applied,
a summary ROC curve rather than a single summary point of
sensitivity and specificity will be estimated.
To compare the accuracy of different instruments, the bi-vari-
ate model will be extended with covariates indicating the type of
instrument. This allows for formal comparison of differences in
mean sensitivity and/or specificity between instruments. Formal
meta-regression analysis will be performed if at least three studies
are included in each subgroup.
All statistical analyses will be performed with statistical software
SAS, release 9.1 (SAS Institute Inc., Cary, North Carolina, USA).
Investigations of heterogeneity
The following factors will be examined to determine whether
they are sources of variation in this review: threshold scores, types
of traumatic experiences (e.g. combat, disaster, accidental injury,
crime), time period between the traumatic event and adminis-
tration of the instrument, short (fewer than the 17 items corre-
sponding to the 17 symptoms in the DSM-IV PTSD diagnosis)
versus long (17 or more items) instruments, instruments referring
to PTSD symptoms experienced during the past week versus the
past month (because instruments were found to use either of these
time periods for symptoms assessments), original language instru-
ments versus translations of the original, and differences in the
administration procedure of the reference standard, such as inclu-
sion of the functional impairment criterion in the PTSD diagno-
sis. Study-level covariates will be added to the bi-variate model to
determine whether there are differences in sensitivity or specificity
or both between subgroups of studies based on the level of the co-
variate. We will present absolute differences with 95% confidence
intervals, P values, and reduction in between-study variances. One
exception is the analysis of differences in threshold. We will use
the hierarchical summary ROC approach (HSROC) to analyse
and visualise the impact of differences in threshold.
Sensitivity analyses
We will examine the influence of methodological quality on our
results by comparing results reported in high-quality studies with
those reported in all studies. A study is categorised as a high-
quality study if risk of bias or applicability is judged as “low” on
all QUADAS-2 domains (Whiting 2011). In addition, if studies
with direct comparisons between index tests are included, we will
examine whether results including only these studies differ from
results including all studies.
Assessment of reporting bias
Given the uncertainty about the mechanisms behind reporting
bias in diagnostic accuracy studies and the limited power of avail-
able tests, we will not examine reporting bias in this review.
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A P P E N D I C E S
Appendix 1. OVID MEDLINE Search strategy
OVID MEDLINE
[Target Condition]
1. STRESS DISORDERS, POST-TRAUMATIC/
2. (PTSD or posttrauma* or post trauma* or post-trauma*).tw.
3. or/1-2
[DTA Filter]
4. “SENSITIVITY AND SPECIFICITY”/
5. “LIMIT OF DETECTION”/
6. ROC CURVE/
7. “PREDICTIVE VALUE OF TESTS”/
8. REPRODUCIBILITY OF RESULTS/
9. (validat* or validity or cross-validat*).tw.
10. likelihood ratio*.tw.
11. ((pre-test or pretest or post-test or posttest) adj probabilit*).tw.
12. ((re-test or retest or test-retest) adj reliability).tw.
13. receiver operating characteristic*.tw.
14. (ROC adj5 (analy* or curve or curves)).tw.
15. or/4-14
[Index Test (i) General terms for ‘self-report’ measures]
16. DIAGNOSTIC SELF EVALUATION/
17. SELF-ASSESSMENT/
18. SELF DISCLOSURE/
19. (self adj (administer* or complet* or evalu* or measure* or rate* or rating* or report*)).tw.
20. (self adj2 (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or questionnaire* or scale* or
tool*)).tw.
21. (diagnos* adj (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or measure* or method*1 or
procedure*1 or questionnaire* or scale* or tool*)).tw.
22. (brief instrument* or brief measure* or brief screen*).tw.
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23. QUESTIONNAIRES/
24. Questionnaire*.tw.
[Index Test (ii) Named self-report instruments for PTSD]
25. (impact of event* or IES or IES-R).tw.
26. (BPTSD* or CMS or DEQ or DRPST or DSMPTSD* or DTS or HSCL* or HTQ or LASC or MMPI* or MPSS* or PAS or
PCL* or PDS or PDEQ or PSS-SR or PTSD-Q or SCL-90-R or SPAN or SPTSS or SPRINT or SRIP or SRS-PTSD or TSCYC or
TSI or TSQ or ZIL).tw.
27. (Aberdeen or Los Angeles or Mississippi).ti,ab.
28. (Davidson or Harvard or Hopkins or Horowitz).ti,ab.
29. Minnesota Multiphasic Personality Inventory.ti,ab.
30. Millon Clinical Multiaxial Inventory.tw.
31. (Mood Monitor or M-3).tw.
32. (Penn or Perdue).ti,ab.
33. (Short Post-Traumatic Stress Disorder adj3 Rating Interview).tw.
34. Zelfinventarisatielijst.ti,ab,ot.
35. ((PTSD or posttrauma* or post trauma* or post-trauma* or trauma* or psychotrauma* or stress*) adj3 (checklist* or index or
indexes or indices or inventory or inventories or instrument*1 or questionnaire* or scale* or tool*)).tw.
36. ((PTSD or posttrauma* or post trauma* or post-trauma* or trauma* or psychotrauma* or stress*) adj1 measure*).tw.
37. ((distress* or screening) adj2 (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or questionnaire*
or scale* or tool*)).tw.
38. (screening adj (method*1 or measure* or procedure*)).tw.
39. Screen for Posttraumatic Stress Symptoms.tw.
40. Disaster-Related Psychological Screening Test.tw.
41. Posttraumatic Adjustment Scale.tw.
42. (symptom adj (checklist* or inventory or scale*)).tw.
43. STRESS DISORDERS, POST-TRAUMATIC/di [diagnosis]
44. or/16-43
[Reference Standards]
45. INTERVIEW, PSYCHOLOGICAL/
46. ((PTSD or posttrauma* or post trauma* or post-trauma*) adj3 interview*).tw.
47. ((clinical* or clinician or diagnos* or neuropsychiatric or schedule*or structured or semi-structured or symptom scale) adj3
interview*).tw.
48. ((clinical* or clinician*) adj3 (administered or checklist* or index or indexes or indices or inventory or inventories or instrument*1
or questionnaire* or scale* or tool*)).tw.
49. clinical diagnosis.tw.
50. (CIDI or PTSD-RI or SCID or SI-PTSD).tw.
51. (((PTSD or posttrauma* or post trauma* or post-trauma*) adj3 disorder scale) or CAPS).tw.
52. (PTSD symptom scale-interview or PSS-I).tw.
53. (reaction index or CPTS*).tw.
54. ((PTSD or posttrauma* or post trauma* or post-trauma*) and (DSM* or ICD-10)).tw.
55. STRESS DISORDERS, POST-TRAUMATIC/di [diagnosis]
56. or/45-43
[Combing Searches (i):Target Condition + DTA Filter + Index Tests]
57. (3 and 15 and 44)
[Combing Searches (ii):Target Condition + Index Tests + Reference Standards]
58. (3 and 44 and 56)
[Final set]
59. (57 or 58)
Note on search strategy:
Because the index test is a questionnaire (used for diagnosis and response to treatment) we need to limit the retrieval of large numbers
of irrelevant hits, for example treatment studies where the diagnostic measure has been cited or DTA studies in victims of physical or
psychological trauma but for depression, anxiety, mood, functional status not PTSD. We appreciate that including relevant terms for
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the reference standard also introduces search redundancy but recognise this as a positive effect, increasing the sensitivity of the search
towards STRESS DISORDERS, POST-TRAUMATIC/di [diagnosis].
OVID PsycINFO
A slightly more sensitive search will be used in OVID PsycINFO:
[Target Condition]
1. POSTTRAUMATIC STRESS DISORDERS/
2. (PTSD or posttrauma* or post trauma* or post-trauma*).tw,tm.
3. TRAUMATIC NEUROSIS/ or STRESS REACTIONS/
4. or/1-3
[DTA Filter]
5. TEST RELIABILITY/
6. TEST VALIDITY/
7. (validat* or validity or cross-validat*).tw.
8. likelihood ratio*.tw.
9. ((pre-test or pretest or post-test or posttest) adj probabilit*).tw.
10. ((re-test or retest or test-retest) adj reliability).tw.
11. receiver operating characteristic*.tw.
12. (ROC adj5 (analy* or curve or curves)).tw.
13. ((screening or diagnostic) adj (checklist*1 or index or indexes or indices or inventory or inventories or instrument*1 or measure*1
or method or procedure*1 or questionnaire*1 or scale* or tool*1)).tw,tm.
14. or/5-13
[Index Test (i) General terms for ‘self-report’ measures]
15. SELF DISCLOSURE/
16. SELF REPORT/
17. (self adj (administer* or complet* or evalu* or measure* or rate* or rating* or report*)).tw,tm.
18. (self adj2 (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or questionnaire* or scale* or
tool*)).tw,tm.
19. (diagnos* adj (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or measure* or method*1 or
procedure*1 or questionnaire* or scale* or tool*)).tw,tm.
20. (brief instrument* or brief measure* or brief screen*).tw,tm.
21. QUESTIONNAIRES/
22. Questionnaire*.tw.
[Index Test (ii) Named self-report instruments for PTSD]
23. (impact of event* or IES or IES-R).tw,tm.
24. (BPTSD* or CMS or DEQ or DRPST or DSMPTSD* or DTS or HSCL* or HTQ or LASC or MMPI* or MPSS* or PAS or
PCL* or PDS or PDEQ or PSS-SR or PTSD-Q or SCL-90-R or SPAN or SPTSS or SPRINT or SRIP or SRS-PTSD or TSCYC or
TSI or TSQ or ZIL).tw,tm.
25. (Aberdeen or Los Angeles or Mississippi).ti,ab,tm.
26. (Davidson or Harvard or Hopkins or Horowitz).ti,ab,tm.
27. Minnesota Multiphasic Personality Inventory.ti,ab.
28. Millon Clinical Multiaxial Inventory.tw,tm.
29. (Mood Monitor or M-3).tw,tm.
30. (Penn or Perdue).ti,ab,tm.
31. (Short Post-Traumatic Stress Disorder adj3 Rating Interview).tw.
32. Zelfinventarisatielijst.ti,ab,ot,tm.
33. ((PTSD or posttrauma* or post trauma* or post-trauma* or trauma* or psychotrauma* or stress*) adj3 (checklist* or index or
indexes or indices or inventory or inventories or instrument*1 or questionnaire* or scale* or tool*)).tw.
34. ((PTSD or posttrauma* or post trauma* or post-trauma* or trauma* or psychotrauma* or stress*) adj1 measure*).tw.
35. ((distress* or screening) adj2 (checklist* or index or indexes or indices or inventory or inventories or instrument*1 or questionnaire*
or scale* or tool*)).tw.
36. (screening adj (method*1 or measure* or procedure*)).tw.
37. Screen for Posttraumatic Stress Symptoms.tw,tm.
38. Disaster-Related Psychological Screening Test.tw,tm.
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39. Posttraumatic Adjustment Scale.tw,tm.
40. (symptom adj (checklist* or inventory or scale*)).tw.
41. or/15-40
[Reference Standards]
42. exp PSYCHODIAGNOSTIC INTERVIEW/
43. INTERVIEWS/
44. ((PTSD or posttrauma* or post trauma* or post-trauma*) adj3 interview*).tw,tm.
45. ((clinical* or clinician or diagnos* or neuropsychiatric or schedule*or structured or semi-structured or symptom scale) adj3
interview*).tw,tm.
46. ((clinical* or clinician*) adj3 (administered or checklist* or index or indexes or indices or inventory or inventories or instrument*1
or questionnaire* or scale* or tool*)).tw.
47. (clinic* adj1 diagnos*).tw,tm.
48. (CIDI or PTSD-RI or SCID or SI-PTSD).tw,tm.
49. (((PTSD or posttrauma* or post trauma* or post-trauma*) adj3 disorder scale) or CAPS).tw,tm.
50. (PTSD symptom scale-interview or PSS-I).tw,tm.
51. (reaction index or CPTS*).tw.
52. ((PTSD or posttrauma* or post trauma* or post-trauma*) and (DSM* or ICD-10)).tw,tm.
53. or/42-52
[Combing Searches (Target Condition + DTA Filter) OR (Target Condition + Index Tests + Reference Standards)]
54. (4 and 14 ) or (4 and 41and 53)
Key:
ti=Title only; tw=Text Word [title; abstract; keywords; references]; ot=Original Title; tm=Test and Measures
Appendix 2. QUADAS-2
QUADAS-2 (Whiting 2011)
Phase 1: State the review question
Patients (setting, intended use of index test, presentation, prior testing)
:
Index test(s):
Reference standard and target condition:
Phase 2: Draw a flow diagram for the primary study
DOMAIN 1: PATIENT SELECTION
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(Continued)
A. Risk of Bias
Describe methods of patient selection:
1. Was a consecutive or random sample of patients enrolled? Yes/No/Unclear
2. Was a case-control design avoided? Yes/No/Unclear
3. Did the study avoid inappropriate exclusions? Yes/No/Unclear
Could the selection of patients have introduced bias? RISK: LOW/HIGH/UNCLEAR
B. Concerns regarding applicability
Describe included patients (prior testing, presentation, intended
use of index test and setting):
Is there concern that the included patients do not match the
review question?
CONCERN: LOW/HIGH/UNCLEAR
DOMAIN 2: INDEX TEST(S)
If more than one index test was used, please complete for each
test.
A. Risk of Bias
Describe the index test and how it was conducted and interpreted:
1. Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes/No/Unclear
2. If a threshold was used, was it pre-specified? Yes/No/Unclear
3. Was internal consistency within an acceptable range (i.e. was
Cronbach’s alpha higher than .70; Bernstein & Nunnally 1994)
Yes/No/Unclear
Could the conduct or interpretation of the index test have
introduced bias?
RISK:
LOW /HIGH/UNCLEAR
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(Continued)
B. Concerns regarding applicability
Is there concern that the index test, its conduct or interpretation
differ from the review question?
CONCERN: LOW/HIGH/UNCLEAR
DOMAIN 3: REFERENCE STANDARD
A. Risk of Bias
Describe the reference standard and how it was conducted and
interpreted:
1. Is the reference standard likely to correctly classify the target
condition?
Yes/No/Unclear
2. Were the reference standard results interpreted without knowl-
edge of the results of the index test?
Yes/No/Unclear
3. Was the DSM-IV criterion F (clinically significant distress or
functional impairment) included in the PTSD diagnosis?
Yes/No/Unclear
4. Were data on interviewer variation (i.e. inter-rater reliability
or agreement) for the semi-structured interview within an accept-
able range (i.e. Cohen’s kappa or Intraclass correlation coefficient
higher than .60; Landis 1977)?
Yes/No/Unclear
Could the reference standard, its conduct, or its interpretation
have introduced bias?
RISK:
LOW /HIGH/UNCLEAR
B. Concerns regarding applicability
Is there concern that the target condition as defined by the
reference standard does not match the review question?
CONCERN: LOW/HIGH/UNCLEAR
DOMAIN 4: FLOW AND TIMING
A. Risk of Bias
Describe any patients who did not receive the index test(s) and/or
reference standard or who were excluded from the 2x2 table (refer
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(Continued)
to flow diagram):
Describe the time interval and any interventions between index
test(s) and reference standard:
1. Was the time interval between administration of the index test
(s) and reference standard less than 8 days?
Yes/No/Unclear
2. Did all patients receive a reference standard? Yes/No/Unclear
3. Did patients receive the same reference standard? Yes/No/Unclear
4. Were all patients included in the analysis? Yes/No/Unclear
Could the patient flow have introduced bias? RISK:
LOW /HIGH/UNCLEAR
C O N T R I B U T I O N S O F A U T H O R S
MS has written the protocol, and all authors have commented on it. MS and NPR will screen the titles and abstracts retrieved by the
searches, with disagreements resolved by consultation with JBR. MS, NPR and LPS will extract all relevant data from included studies
and will assess studies using the QUADAS-2 instrument. MS and JBR will perform statistical analyses. All authors will contribute to
the final review.
D E C L A R A T I O N S O F I N T E R E S T
None declared.
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